Collaborative webinar: economic modelling in rare diseases

Mar 2, 2021

Watch the recording

 

It can be challenging to develop an economic model in rare diseases that optimises HTA and reimbursement outcomes. It can be difficult to fully capture the effects of the disease and the benefits of treatment whilst using sufficiently robust data to minimise uncertainty.

This webinar introduces a new approach in which multiple companies collaborate to develop a core economic model and common data set. An approach that aims to optimise HTA and reimbursement outcomes for all new treatments in a rare disease.

Speakers: Prof. Keith Abrams, Prof. John Brazier, Dr. Jill CarltonJosie GodfreyJamie O’Hara, Dr Mark Larkin, PhD, and Juliet Mumby-Croft

JG ZEBRA CONSULTING LTDHCD Economics LtdUniversity of LeicesterUniversity of YorkThe University of SheffieldVitaccessSource Health Economics.

#ProjectHERCULES #rarediseases #heor #healtheconomics #evidencebasedmedicine #pharmaceuticalindustry

More Insights

National Numeracy Day 2024: making maths work for women and girls

National Numeracy Day 2024: making maths work for women and girls

Written by Abby Paine, Holly Pilkington, and Dom Partridge   Two years ago we wrote a blog for National Numeracy Day 2022, and enjoyed the process so much that we thought we would write another one! Last time, we wrote about network ... Read more

Quality assessment in single-arm trials: insights for systematic reviews

Quality assessment in single-arm trials: insights for systematic reviews

Written by Hannah Shapiro   Quality assessment in single-arm trials Quality assessment is a vital aspect of conducting a thorough systematic literature review (SLR), as the validity of the conclusions of the review depends on the ... Read more

A ‘NICE’ Innovation: The Proportionate Approach

A ‘NICE’ Innovation: The Proportionate Approach

Written by Kiera Lander, Assistant Project Manager   The National Institute for Health and Care Excellence (NICE) has long been at the forefront of health technology assessment (HTA), ensuring that patients have access to innovative, ... Read more

Out of the frying pan and into the fire: Moving to a market access consultancy company

Out of the frying pan and into the fire: Moving to a market access consultancy company

Written by Brian O'Toole, HTA Writing Lead   Last year I changed jobs. It was a major life decision that took time to make as it meant leaving the comfort and familiarity of academia for the hustle and bustle of a market access ... Read more